Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Valentine

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Clinical and Diagnostic Laboratory Immunology|September 6, 2000
Shipment impairs lymphocyte proliferative responses to microbial antigensR A Betensky, E Connick, J Devers, et al.
The American Journal of Clinical Nutrition|April 7, 2007
Holo-transcobalamin is an indicator of vitamin B-12 absorption in healthy adults with adequate vitamin B-12 statusKristina M von Castel-Roberts, Anne Louise Morkbak, Ebba Nexo, et al.
Inflammatory Bowel Diseases|May 20, 2015
Briakinumab for treatment of Crohn's disease: results of a randomized trialRemo Panaccione, William J Sandborn, Glenn L Gordon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2012
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel diseaseUma Mahadevan, Douglas C Wolf, Marla Dubinsky, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 30, 2018
Family History Associates With Increased Risk of Colorectal Cancer in Patients With Inflammatory Bowel DiseasesN Jewel Samadder, John F Valentine, Stephen Guthery, et al.
Journal of Crohn'S & Colitis|January 15, 2024
Increased Activity of MAPKAPK2 within Mesenchymal Cells as a Target for Inflammation-Associated Fibrosis in Crohn's DiseaseMarina Chulkina, Christina Rohmer, Steven McAninch, et al.
The Lancet. Gastroenterology & Hepatology|October 14, 2022
Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trialWilliam J Sandborn, Julian Panés, Silvio Danese, et al.
Gastrointestinal Endoscopy|December 27, 2011
Randomized, controlled trial of standard, large-capacity versus jumbo biopsy forceps for polypectomy of small, sessile, colorectal polypsPeter V Draganov, Myron N Chang, Ahmad Alkhasawneh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2023
Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER)Jean-Frederic Colombel, Ryan C Ungaro, Bruce E Sands, et al.
Digestive Diseases and Sciences|January 5, 2017
Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in UtahN Jewel Samadder, John F Valentine, Stephen Guthery, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Clinical and Diagnostic Laboratory Immunology|September 6, 2000
Shipment impairs lymphocyte proliferative responses to microbial antigensR A Betensky, E Connick, J Devers, et al.
The American Journal of Clinical Nutrition|April 7, 2007
Holo-transcobalamin is an indicator of vitamin B-12 absorption in healthy adults with adequate vitamin B-12 statusKristina M von Castel-Roberts, Anne Louise Morkbak, Ebba Nexo, et al.
Inflammatory Bowel Diseases|May 20, 2015
Briakinumab for treatment of Crohn's disease: results of a randomized trialRemo Panaccione, William J Sandborn, Glenn L Gordon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2012
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel diseaseUma Mahadevan, Douglas C Wolf, Marla Dubinsky, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 30, 2018
Family History Associates With Increased Risk of Colorectal Cancer in Patients With Inflammatory Bowel DiseasesN Jewel Samadder, John F Valentine, Stephen Guthery, et al.
Journal of Crohn'S & Colitis|January 15, 2024
Increased Activity of MAPKAPK2 within Mesenchymal Cells as a Target for Inflammation-Associated Fibrosis in Crohn's DiseaseMarina Chulkina, Christina Rohmer, Steven McAninch, et al.
The Lancet. Gastroenterology & Hepatology|October 14, 2022
Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trialWilliam J Sandborn, Julian Panés, Silvio Danese, et al.
Gastrointestinal Endoscopy|December 27, 2011
Randomized, controlled trial of standard, large-capacity versus jumbo biopsy forceps for polypectomy of small, sessile, colorectal polypsPeter V Draganov, Myron N Chang, Ahmad Alkhasawneh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2023
Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER)Jean-Frederic Colombel, Ryan C Ungaro, Bruce E Sands, et al.
Digestive Diseases and Sciences|January 5, 2017
Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in UtahN Jewel Samadder, John F Valentine, Stephen Guthery, et al.
Pageof 10